Average Co-Inventor Count = 3.33
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Alnylam Pharmaceuticals, Inc. (4 from 444 patents)
2. Alnylam Europe Ag (1 from 3 patents)
5 patents:
1. 8034793 - RNAi modulation of MLL-AF4 and uses thereof
2. 7846907 - Double-stranded RNA (dsRNA) and method of use for inhibiting expression of a fusion gene
3. 7674779 - RNAi modulation of MLL-AF4 and uses thereof
4. 7361752 - RNAi modulation of MLL-AF4 and uses thereof
5. 7196184 - Double-stranded RNA (DSRNA) and method of use for inhibiting expression of the AML-1/MTG8 fusion gene